Comparing resveratrol gel and TCA for melasma
Part of Skin clinical trials.
This study compares two topical treatments for melasma: a resveratrol gel and trichloroacetic acid (TCA) solution. Each side of your face gets a different treatment, so you can see which works better for your skin.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 50 years old.
- You must have melasma on both sides of your face, in a matching pattern.
- Your skin tone must be in the medium to dark range (Fitzpatrick types III, IV, or V).
- You must not be pregnant or breastfeeding.
- You must not be taking birth control pills, hormone therapy, or other chronic medications now or within the past 6 months.
- You must not have a history of scarring or keloids, active skin infections, or other conditions that cause dark spots.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two topical creams — one with tranexamic acid and one with vitamin C (ethyl ascorbic acid) — to see which works better for treating melasma. If you have melasma and meet the health criteria, you may be able to join and receive one of these treatments.
This study compares two treatments for melasma: injecting tranexamic acid into the skin versus applying a mandelic acid facial peel. The goal is to see which one works better at lightening the dark patches on your face.
This study compares two creams — metformin and tranexamic acid — to see which works better for melasma (dark patches on the face). If you qualify, you'll use one of the creams and your progress will be checked over time.
This study compares two different combination creams for treating melasma, a common skin condition causing dark patches on the face. One cream includes a mild steroid and the other has a different steroid, both with the same lightening ingredients. The goal is to see which works better and is safer for your skin.
This trial tests two injectable treatments for melasma (dark patches on the face): platelet-rich fibrin, which uses your own blood cells to promote healing, and tranexamic acid, a medication that may reduce pigmentation. The study will compare which works better for women with mild to moderate melasma.
This study compares two different creams applied to the skin — metformin and ketotifen — to see which works better for treating melasma (dark patches on the face). If you are a woman with melasma, you may be eligible to join and receive one of these creams.
Hear when a new Melasma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.